Ticker
KURACompany Name
KURA ONCOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash and Equivalents | Cash Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 81.95M | 0.76 | $ 107.17M |
3/31/2025 | $ 51.27M | 0.57 | $ 89.77M |
12/31/2024 | $ 224.46M | 2.85 | $ 78.71M |
9/30/2024 | $ 49.48M | 1.23 | $ 40.37M |
6/30/2024 | $ 45.18M | 1.35 | $ 33.45M |
3/31/2024 | $ 41.51M | 1.29 | $ 32.27M |
12/31/2023 | $ 37.32M | 1.06 | $ 35.26M |
9/30/2023 | $ 28.74M | 1.04 | $ 27.52M |
6/30/2023 | $ 49.33M | 2.06 | $ 23.9M |
3/31/2023 | $ 27.27M | 1.42 | $ 19.23M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for KURA ONCOLOGY INC is calculated as follows: CashnEq [ $ 77.17M ] / LiabilitesC [ $ 21.7M ]
(=) Cash Ratio [ 3.56 ]
Minimum
Mar 31, 2025
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.13K |
---|---|
min | 0 |
max | 2.69 |
average | 0.62 |
median | 0.39 |
std | 0.63 |